Clofazimine as a Treatment for Multidrug-Resistant Tuberculosis: A Review
Multidrug-resistant tuberculosis (MDR-TB) is an infectious disease caused by <i>Mycobacterium tuberculosis</i> which is resistant to at least isoniazid and rifampicin. This disease is a worldwide threat and complicates the control of tuberculosis (TB). Long treatment duration, a combinat...
| Published in: | Scientia Pharmaceutica |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-05-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-0532/89/2/19 |